TY - JOUR
T1 - Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages
AU - Rosenbluth, Jennifer M.
AU - Schackmann, Ron C.J.
AU - Gray, G. Kenneth
AU - Selfors, Laura M.
AU - Li, Carman Man Chung
AU - Boedicker, Mackenzie
AU - Kuiken, Hendrik J.
AU - Richardson, Andrea
AU - Brock, Jane
AU - Garber, Judy
AU - Dillon, Deborah
AU - Sachs, Norman
AU - Clevers, Hans
AU - Brugge, Joan S.
N1 - Funding Information:
We would like to acknowledge the exceptional team who facilitated tissue acquisition for these studies, including the Brigham and Women’s Hospital (BWH) breast surgery team led by Tari King, MD, plastic surgery team Indranil Sinha, MD and Bo Pomahac, MD, the BWH Faulkner pathologists led by Stephen Pochebit, MD, and the specimen collection group led by Samantha Stokes and the Breast Biorepository staff. We also thank Amgen for providing RANK antibody (N1H8) for use in the CyTOF experiments, Jon Coloff for providing MCF10A cells grown in 3D culture, Alexis Cook for technical assistance, Angie Martinez Gakidis for critical reading of the manuscript, Wendy Fantl for advice on CyTOF, David Livingston and Shailja Pathania for BRCA1 antibody and immortalized HMECs, Calvin Kuo for R-spondin 1-expressing 293 cells, and The Nikon Imaging Center at Harvard Medical School for assistance with imaging. This work was supported by the grants from the BRCA Foundation, Susan G Komen Foundation, the Gray Foundation and a gift from the Anbinder Fund for Cancer Research to J.S.B., an ACS Postdoctoral Fellowship, a Susan G Komen Foundation award, and an ASCO Young Investigator Award to J.M.R., a F32 fellowship to G.K.G., and a SPORE Grant (1P50CA168504) to Dana-Farber/Harvard Cancer Center, and a Breast Cancer Research Foundation grant to J.G.
Publisher Copyright:
© 2020, The Author(s).
PY - 2020/12/1
Y1 - 2020/12/1
N2 - Recently, organoid technology has been used to generate a large repository of breast cancer organoids. Here we present an extensive evaluation of the ability of organoid culture technology to preserve complex stem/progenitor and differentiated cell types via long-term propagation of normal human mammary tissues. Basal/stem and luminal progenitor cells can differentiate in culture to generate mature basal and luminal cell types, including ER+ cells that have been challenging to maintain in culture. Cells associated with increased cancer risk can also be propagated. Single-cell analyses of matched organoid cultures and native tissues by mass cytometry for 38 markers provide a higher resolution representation of the multiple mammary epithelial cell types in the organoids, and demonstrate that protein expression patterns of the tissue of origin can be preserved in culture. These studies indicate that organoid cultures provide a valuable platform for studies of mammary differentiation, transformation, and breast cancer risk.
AB - Recently, organoid technology has been used to generate a large repository of breast cancer organoids. Here we present an extensive evaluation of the ability of organoid culture technology to preserve complex stem/progenitor and differentiated cell types via long-term propagation of normal human mammary tissues. Basal/stem and luminal progenitor cells can differentiate in culture to generate mature basal and luminal cell types, including ER+ cells that have been challenging to maintain in culture. Cells associated with increased cancer risk can also be propagated. Single-cell analyses of matched organoid cultures and native tissues by mass cytometry for 38 markers provide a higher resolution representation of the multiple mammary epithelial cell types in the organoids, and demonstrate that protein expression patterns of the tissue of origin can be preserved in culture. These studies indicate that organoid cultures provide a valuable platform for studies of mammary differentiation, transformation, and breast cancer risk.
UR - http://www.scopus.com/inward/record.url?scp=85083022641&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85083022641&partnerID=8YFLogxK
U2 - 10.1038/s41467-020-15548-7
DO - 10.1038/s41467-020-15548-7
M3 - Article
C2 - 32249764
AN - SCOPUS:85083022641
SN - 2041-1723
VL - 11
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 1711
ER -